AgeX Therapeutics Inc.

(NYSE:AGE)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

AgeX Therapeutics Inc is a biotechnology company engaged in the development and commercialization of novel therapeutics targeting human aging. The firm through its PureStem and induced Tissue Regeneration (iTR) technologies develop innovative medicines designed to address some of the unsolved problems in aging. Its PureStem derived cell-based therapeutic candidates in development are AGEX-VASC1 and AGEX-BAT1. And iTR drug-based therapeutic candidates in development are AGEX-iTR1547 and Renelon.

Contact Information

Website: www.agexinc.com
Main Phone: +1 510 871-4190
Address: 1010 Atlantic Avenue
Address 2: Suite 102
State: CA
City / Town: Alameda
Country: US
Postal Code: 94501

Issuer Information

Exchange: AMX
CEO: Michael D. West
Employees: 17
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A